NEW YORK, Oct. 18, 2022 (GLOBE NEWSWIRE) — Research Nester has published an in-depth market report on “Global Hemostasis Products market‘ for the forecast period, i.e. 2023 – 2033, which includes the following factors:
- Market growth over the forecast period
- Detailed regional summary
- market segmentation
- growth accelerator
- challenges
- Key market players and their detailed profiling
Global Hemostasis Products Market Size:
In 2022, the global hemostatic products market generated revenue of nearly US$1,650 million. Revenue of approximately $1,734.2 million is expected by the end of 2033. The growth of the market is driven by the increasing number of traffic accidents resulting in serious injuries and incessant bleeding victims. Hemostatics are highly efficient at controlling bleeding and clamping blood vessels. According to the World Health Organization, traffic accidents cause nearly 1.3 million deaths annually and are the leading cause of death among people aged 5 to 29. In addition, nearly 3,700 people worldwide lose their lives in auto accidents every day. The resulting fatal and non-fatal injuries cost the global economy nearly $8 trillion. There is also an increased need for blood transfusions and blood donations. The use of hemostatic agents minimizes the risk of complications during the transfusion. The World Health Organization estimates that the global burden of blood transfusions is nearly 76% for adults aged 60 and over and nearly 54% for adolescents.
Request a PDF sample brochure: https://www.researchnester.com/sample-request-4447
Global Hemostasis Products Market: The central theses
- The North America region generates the majority of sales
- The orthopedic surgery segment dominates the revenue chart
- The hospitals sub-segment remains prominent in the end-user segment
Increasing cancer cases and surge in surgical interventions are projected to boost market growth
The patient with cancer develops hypercoagulability over time and some even…
